These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 7518491

  • 1. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 2. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
    Cucuianu M, Knauer O, Roman S.
    Thromb Haemost; 1991 Nov 01; 66(5):586-91. PubMed ID: 1725069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
    Nanninga PB, van Teunenbroek A, Veenhof CH, Büller HR, ten Cate JW.
    Thromb Haemost; 1990 Nov 30; 64(3):361-4. PubMed ID: 1710832
    [Abstract] [Full Text] [Related]

  • 7. Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease.
    Vaziri ND, Winer RL, Gonzales EV, Eltorai IM.
    J Am Paraplegia Soc; 1993 Jul 30; 16(3):149-52. PubMed ID: 7690062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND, Gonzales E, Barton CH, Chen HT, Nguyen Q, Arquilla M.
    J Lab Clin Med; 1991 Feb 30; 117(2):152-6. PubMed ID: 1993857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW.
    Thromb Haemost; 1993 Feb 01; 69(2):141-6. PubMed ID: 7681223
    [Abstract] [Full Text] [Related]

  • 18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 01; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
    Kamper EF, Kopeikina LT, Koutsoukos V, Stavridis J.
    J Rheumatol; 1997 Feb 01; 24(2):262-8. PubMed ID: 9034981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.